Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Freo U, Brugnatelli V, Turco F, Zanette G
Isoprostanes: markers and mediators of oxidative stress
Based on the significant unmet medical need in the treatment of GAD along with the initial clinical data from the Phase 2b study and other research conducted by MindMed, the U.S
With insurance coverage, patients might pay as little as $25/mo
Phase 3 studies specifically targeting NASH as a primary indication are ongoing
US$ 27.92
US$ 27.29
US$ 28.99
US$ 28.81
US$ 29.09
